The study in Kisumu, western Kenya, found that the triple combination of antiretroviral (ARV) drugs given to HIV-infected mothers to prevent transmission of the virus to their infants was effective and feasible, but there were cases of possible drug resistance in HIV-positive infants. Read on.
